menu search

IMVT / These 2 Biotech Stocks Are Bucking a Down Market Tuesday

These 2 Biotech Stocks Are Bucking a Down Market Tuesday
Markets moved lower on Tuesday, giving up some gains from Monday. Immunovant released positive trial data that sent its shares soaring. Read More
Posted: Sep 26 2023, 09:10
Author Name: The Motley Fool
Views: 112538

IMVT News  

Why Immunovant Stock Is Bolting Higher Today

By The Motley Fool
September 27, 2023

Why Immunovant Stock Is Bolting Higher Today

Tuesday, Immunovant announced early-stage trial results for an autoimmune disease candidate that caused its shares to rocket higher. Investors are bid more_horizontal

Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock

By Seeking Alpha
September 27, 2023

Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock

Although Immunovant's stock has rallied around 100% since January, recent data on its therapeutic candidate, IMVT-1402, has further bolstered confiden more_horizontal

Immunovant Shares Skyrocket After Trial of Its Autoimmune Drug Beats Expectations

By Investopedia
September 26, 2023

Immunovant Shares Skyrocket After Trial of Its Autoimmune Drug Beats Expectations

Immunovant (IMVT) shares virtually doubled on Tuesday after the biopharmaceutical company reported positive results from a Phase 1 trial of its experi more_horizontal

Why Shares of Immunovant Are Soaring on Tuesday

By The Motley Fool
September 26, 2023

Why Shares of Immunovant Are Soaring on Tuesday

Immunovant reported positive phase 1 trial data for IMVT-1402. The company said the therapy showed a strong safety profile and fewer side effects than more_horizontal

Immunovant and Roivant jump as new drug shapes up to become blockbuster

By Proactive Investors
September 26, 2023

Immunovant and Roivant jump as new drug shapes up to become blockbuster

There was a bumper boost for stock in two Nasdaq-listed biotechs premarket after an experimental antibody treatment was revealed to have blockbuster p more_horizontal

These 2 Biotech Stocks Are Bucking a Down Market Tuesday

By The Motley Fool
September 26, 2023

These 2 Biotech Stocks Are Bucking a Down Market Tuesday

Markets moved lower on Tuesday, giving up some gains from Monday. Immunovant released positive trial data that sent its shares soaring. more_horizontal

Immunovant to Host Conference Call and Webcast to Report Initial IMVT-1402 Phase 1 Results on September 26, 2023

By GlobeNewsWire
September 25, 2023

Immunovant to Host Conference Call and Webcast to Report Initial IMVT-1402 Phase 1 Results on September 26, 2023

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives f more_horizontal

Immunovant (IMVT) Q1 Loss Wider Y/Y, Pipeline in Focus

By Zacks Investment Research
August 11, 2023

Immunovant (IMVT) Q1 Loss Wider Y/Y, Pipeline in Focus

Immunovant's (IMVT) reports wider-than-expected loss for fiscal first-quarter 2023. IMVT is on track with the pipeline developments. more_horizontal


Search within

Pages Search Results: